FIRST TACE RESPONSE AND POSSIBILITY FOR RETACE
| FIRST TACE | RE-TACE | ||||||
|---|---|---|---|---|---|---|---|
| Scoring System | 'Six-and-twelve' Score | ALBI-TAE | STATE Score | ART Score | SNACOR Model | ABCR Score | mHAP-III Score |
| Group Classifications (Median Survival in Months) | <6: 49.1 months 6-12: 32.0 months >12: 15.8 months | Group A (score 0): 65.9 months Group B (score 1): 30.2 months Group C (score 2): 17.4 months Group D (score 3): 6.0 months | <18: 5.3 months ≥18: 19.5 months | 0 to 1.5: 23.7 months ≥2.5: 6.6 months | 0 to 2: 49.8 months 3 to 6: 30.7 months 7 to 10: 12.4 months | ≤0: 37.8 months 1 to 3: 17.1 months ≥4: 7.5 months | Calculated using a web-based tool; survival varies |
| Study Cohort | 1604 patients from 24 Chinese tertiary referral centers | 570 patients from Taipei Veterans Hospital | 277 patients from two Austrian centers | 222 patients from two Austrian centers | 485 patients from two Korean centers | 317 patients from two French centers | 385 patients from two Italian centers |